Detailed Hypertension Treatment Protocol by Blood Pressure Level
For Stage 1 hypertension (SBP 130-139 or DBP 80-89 mmHg), initiate monotherapy with a single first-line agent and titrate; for Stage 2 hypertension (SBP ≥140 or DBP ≥90 mmHg), start with combination therapy using two drugs from different classes, preferably as a single-pill combination. 1
Stage 1 Hypertension Protocol (SBP 130-139 or DBP 80-89 mmHg)
Initial Treatment Approach
- Use stepped-care monotherapy unless the patient is non-Hispanic Black or has ASCVD risk >7.5%, in which case start with dual therapy 1
- The stepped-care approach means starting with one drug, titrating to maximum tolerated dose, then adding sequential agents if needed 1, 2
First-Line Drug Options (Choose ONE):
- Thiazide/thiazide-like diuretic: Chlorthalidone 12.5-25 mg once daily OR Hydrochlorothiazide 12.5-25 mg once daily 3
- ACE inhibitor: Enalapril 5-10 mg once daily (can titrate to 40 mg daily) 3
- ARB: Candesartan 8-16 mg once daily (can titrate to 32 mg daily) 3
- Calcium channel blocker: Amlodipine 2.5-5 mg once daily (can titrate to 10 mg daily) 3
Titration Strategy:
- Start at lowest dose
- Titrate to maximum tolerated dose over 2-4 weeks
- If BP remains ≥20/10 mmHg above target after maximizing first drug, add second agent from different class 1
Special Populations in Stage 1:
- High-risk patients (ASCVD risk >7.5%, non-Hispanic Black adults): Start with two-drug combination even in Stage 1 1
- Older adults: Use stepped-care approach due to hypotension/orthostatic hypotension risk 1, 2
Stage 2 Hypertension Protocol (SBP ≥140 or DBP ≥90 mmHg)
Initial Treatment Approach
Start with two-drug combination therapy from different classes, preferably as a single-pill combination (SPC) 1, 2
Why Combination Therapy?
- Patients with SBP ≥20 mmHg or DBP ≥10 mmHg above target require multiple agents for control 1, 2
- SPCs improve adherence, reduce cardiovascular events, and lower all-cause mortality compared to separate pills 1, 2
- Once-daily dosing in SPC format maximizes adherence 1
Preferred Two-Drug Combinations:
Option 1: ACE inhibitor/ARB + Calcium Channel Blocker
- Enalapril 5-10 mg + Amlodipine 5 mg once daily
- Candesartan 16 mg + Amlodipine 5 mg once daily
Option 2: ACE inhibitor/ARB + Thiazide Diuretic
- Enalapril 10 mg + Hydrochlorothiazide 12.5-25 mg once daily
- Candesartan 16 mg + Hydrochlorothiazide 12.5-25 mg once daily
Option 3: Calcium Channel Blocker + Thiazide Diuretic
- Amlodipine 5 mg + Hydrochlorothiazide 12.5-25 mg once daily
- Amlodipine 5 mg + Chlorthalidone 12.5-25 mg once daily
Step 2: Dose Intensification (if BP not at target after 2-4 weeks)
- Increase doses of both agents to maximum tolerated levels 4
- Example: Amlodipine 5 mg → 10 mg; Enalapril 10 mg → 20-40 mg
Step 3: Add Third Agent (if BP remains elevated)
Add a drug from the remaining first-line class not yet used:
- If on ACEi/ARB + CCB → add thiazide diuretic
- If on ACEi/ARB + thiazide → add CCB
- If on CCB + thiazide → add ACEi or ARB
Step 4: Add Fourth Agent (Resistant Hypertension)
Add mineralocorticoid receptor antagonist: Spironolactone 25 mg once daily (can titrate to 50 mg) 5
Critical Drug Combination Rules
NEVER Combine:
- Two RAS blockers together (ACEi + ARB, or either with aliskiren) - increases CVD risk, kidney disease, and hyperkalemia 1, 2
- Two drugs from same class (e.g., two different ACE inhibitors, two beta-blockers, two dihydropyridine CCBs) 1, 2
EXCEPTIONS - Can Combine:
- Thiazide + potassium-sparing diuretics 1, 2
- Thiazide + loop diuretics 1, 2
- Dihydropyridine CCB + non-dihydropyridine CCB (in selected patients) 1, 2
Blood Pressure Targets
- Adults <65 years: SBP <130 mmHg and DBP <80 mmHg 3
- Adults ≥65 years: SBP <130 mmHg 3
- Diabetes or CKD: SBP <130 mmHg and DBP <80 mmHg 3
Key Clinical Pitfalls to Avoid
Don't delay combination therapy in Stage 2 hypertension - monotherapy is insufficient in most cases and delays BP control 1, 2
Avoid multiple daily dosing - once-daily regimens dramatically improve adherence 1
Don't use free-pill combinations when SPCs are available - SPCs reduce cardiovascular events and mortality 1, 2
Monitor older adults closely when initiating therapy - they're at higher risk for hypotension and orthostatic hypotension 1, 2
Don't combine RAS blockers - this is harmful, not beneficial 1, 2
Ensure adequate diuretic dosing - hydrochlorothiazide should be at least 12.5-25 mg; chlorthalidone is more potent 3